New hope for controlling debilitating GPA symptoms in the ears, nose, and throat
Disease control
Not yet recruiting
This study is testing if adding the drug TAVNEOS to standard treatment helps people with granulomatosis with polyangiitis (GPA) better control their ear, nose, and throat symptoms. About 30 participants with active GPA affecting these areas will receive either TAVNEOS or a placeb…
Phase: PHASE2, PHASE3 • Sponsor: Robert Spiera, MD • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC